-
-
-
-
-
-
-
Crinetics Pharmaceuticals (CRNX) Prices Upsized 10M Share Offering at $50/sh
-
-
-
-
-
-
-
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

